Your browser doesn't support javascript.
loading
PAPP-A negatively regulates ABCA1, ABCG1 and SR-B1 expression by inhibiting LXRα through the IGF-I-mediated signaling pathway.
Tang, Shi-Lin; Chen, Wu-Jun; Yin, Kai; Zhao, Guo-Jun; Mo, Zhong-Cheng; Lv, Yun-Cheng; Ouyang, Xin-Ping; Yu, Xiao-Hua; Kuang, Huai-Jun; Jiang, Zhi-Sheng; Fu, Yu-Chang; Tang, Chao-Ke.
Afiliação
  • Tang SL; Institute of Cardiovascular Research, Key Laboratory for Atherosclerology of Hunan Province, Life Science Research Center, University of South China, Hengyang, Hunan 421001, China.
Atherosclerosis ; 222(2): 344-54, 2012 Jun.
Article em En | MEDLINE | ID: mdl-22503545
Pregnancy-associated plasma protein-A (PAPP-A) has been involved in the atherosclerotic process through regulation of local expression of IGF-1 that mediates the activation of the phosphatidylinositol-3 (PI3-K) and Akt kinase (Akt) signaling cascades which lead to constitutive nitric oxide formation, with its attending vasodilator, antiplatelet and insulin-sensitizing actions. In addition, IGF-1 may decreased cholesterol efflux through reductions of expression in ABCA1 and SR-B1 by the PI3-K/Akt signaling pathway. In the current study, we examined whether PAPP-A was involved in LXRα regulation and in expression of ABCA1, ABCG1 or SR-B1 through the IGF-I-mediated signaling pathway (IGF/PI3-K/Akt). Results showed that PAPP-A significantly decreased expression of ABCA1, ABCG1 and SR-BI at both transcriptional and translational levels in a dose-dependent and time-dependent manner. Cellular cholesterol content was increased while cholesterol efflux was decreased by PAPP-A treatment. Moreover, LXRα which can regulate the expression of ABCA1, ABCG1 and SR-B1, was also down-regulated by PAPP-A treatment. LXRα-specific activation by LXRα agonist almost rescued the down-regulation of ABCA1, ABCG1 and SR-B1 expression by PAPP-A. In addition, PAPP-A can induce the IGF-1/PI3-K/Akt pathway in macrophages. Furthermore, our results indicate that the decreased levels observed in LXRα, ABCA1, ABCG1 and SR-B1 mRNA and protein levels upon treating cells with PAPP-A were strongly impaired with the PI3-K inhibitors or IGF-1R siRNA while the MAPK cascade inhibitor did not execute this effect, indicating that the process of ABCA1, ABCG1 and SR-BI degradation by PAPP-A involves the IGF-1/PI3-K/Akt pathway. In conclusion, PAPP-A may first down-regulate expression of LXRα through the IGF-1/PI3-K/Akt signaling pathway and then decrease expression of ABCA1, ABCG1, SR-B1 and cholesterol efflux in THP-1 macrophage-derived foam cells. Therefore, our study provided one of the mechanisms for understanding the critical effect of PAPP-A in pathogenesis of atherosclerosis.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteína Plasmática A Associada à Gravidez / Fator de Crescimento Insulin-Like I / Transdução de Sinais / Transportadores de Cassetes de Ligação de ATP / Aterosclerose / Receptores Depuradores Classe B / Receptores Nucleares Órfãos / Células Espumosas Tipo de estudo: Etiology_studies Limite: Humans Idioma: En Revista: Atherosclerosis Ano de publicação: 2012 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteína Plasmática A Associada à Gravidez / Fator de Crescimento Insulin-Like I / Transdução de Sinais / Transportadores de Cassetes de Ligação de ATP / Aterosclerose / Receptores Depuradores Classe B / Receptores Nucleares Órfãos / Células Espumosas Tipo de estudo: Etiology_studies Limite: Humans Idioma: En Revista: Atherosclerosis Ano de publicação: 2012 Tipo de documento: Article